BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25183169)

  • 1. Infrasellar pituitary gangliocytoma causing Cushing's syndrome.
    Domingue ME; Marbaix E; Do Rego JL; Col V; Raftopoulos C; Duprez T; Vaudry H; Maiter D
    Pituitary; 2015 Oct; 18(5):738-44. PubMed ID: 25183169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cushing's disease in a child caused by a corticotropin-releasing hormone-secreting intrasellar gangliocytoma associated with an adrenocorticotropic hormone-secreting pituitary adenoma.
    Puchner MJ; Lüdecke DK; Valdueza JM; Saeger W; Willig RP; Stalla GK; Odink RJ
    Neurosurgery; 1993 Nov; 33(5):920-4; discussion 924-5. PubMed ID: 8264895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cushing's syndrome with a large pituitary adenoma producing both corticotropin-releasing hormone (CRH) and adrenocorticotropin (ACTH).
    Yamada Y; Ohashi A; Inoue T; Sakaguchi K; Tsujimura T; Okamoto D; Itatani H; Fujimoto N; Kusaka K; Fushimi H
    Intern Med; 2002 Jul; 41(7):549-54. PubMed ID: 12132523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary tumour localization in patients with Cushing's disease by magnetic resonance imaging. Is there a place for petrosal sinus sampling?
    de Herder WW; Uitterlinden P; Pieterman H; Tanghe HL; Kwekkeboom DJ; Pols HA; Singh R; van de Berge JH; Lamberts SW
    Clin Endocrinol (Oxf); 1994 Jan; 40(1):87-92. PubMed ID: 8306486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined sellar gangliocytoma and pituitary adenoma in acromegaly or Cushing's disease. A report of 3 cases.
    Saeger W; Puchner MJ; Lüdecke DK
    Virchows Arch; 1994; 425(1):93-9. PubMed ID: 7921420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
    Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess.
    Colombo P; Passini E; Re T; Faglia G; Ambrosi B
    Clin Endocrinol (Oxf); 1997 Jun; 46(6):661-8. PubMed ID: 9274696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
    Yap LB; Turner HE; Adams CB; Wass JA
    Clin Endocrinol (Oxf); 2002 Jan; 56(1):25-31. PubMed ID: 11849243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary Gangliocytoma Producing TSH and TRH: A Review of "Gangliocytomas of the Sellar Region".
    Sakata K; Fujimori K; Komaki S; Furuta T; Sugita Y; Ashida K; Nomura M; Morioka M
    J Clin Endocrinol Metab; 2020 Oct; 105(10):3109-21. PubMed ID: 32706866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracavernous sinus ectopic adrenocorticotropin-secreting tumours causing therapeutic failure in transsphenoidal surgery for Cushing's disease.
    Ohnishi T; Arita N; Yoshimine T; Mori S
    Acta Neurochir (Wien); 2000; 142(8):855-64. PubMed ID: 11086823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.
    Chrousos GP; Schulte HM; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
    N Engl J Med; 1984 Mar; 310(10):622-6. PubMed ID: 6319991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing's syndrome.
    Reimondo G; Paccotti P; Minetto M; Termine A; Stura G; Bergui M; Angeli A; Terzolo M
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):718-24. PubMed ID: 12780748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Petrosal sinus sampling for diagnosis of Cushing's disease: evidence of false negative results.
    López J; Barceló B; Lucas T; Salame F; Alameda C; Boronat M; Salto L; Estrada J
    Clin Endocrinol (Oxf); 1996 Aug; 45(2):147-56. PubMed ID: 8881446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation, management and therapeutic outcome in 12 cases of childhood and adolescent Cushing's syndrome.
    Weber A; Trainer PJ; Grossman AB; Afshar F; Medbak S; Perry LA; Plowman PN; Rees LH; Besser GM; Savage MO
    Clin Endocrinol (Oxf); 1995 Jul; 43(1):19-28. PubMed ID: 7641408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ACTH secretion in Cushing's adenoma and clinically silent corticotroph adenoma by cell immunoblot assay.
    Kojima Y; Suzuki S; Yamamura K; Ohhashi G; Yamamoto I
    Endocr J; 2002 Jun; 49(3):285-92. PubMed ID: 12201210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the accuracy of inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome].
    Tóth M; Vajda Z; Görömbey Z; Molnár F; Major L; Toke J; Szabolcs I; Szücs N; Kovács L; Kiss R; Czirják S; Füto L; Gláz E; Góth M; Rácz K
    Orv Hetil; 2007 May; 148(18):843-7. PubMed ID: 17468067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult eutopic Cushing's syndrome--failure of simultaneous bilateral petrosal sinus sampling to diagnose pituitary-dependent Cushing's syndrome.
    Heppner C; Becker K; Saeger W; Günther RW; Allolio B; Krone W; Winkelmann W
    Eur J Endocrinol; 1997 Jul; 137(1):74-8. PubMed ID: 9242205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACTH response to desmopressin in a patient with acromegaly; expression of corticotropin-releasing factor, urocortins and vasopressin V1b receptor in GH-producing pituitary adenoma.
    Arihara Z; Sakurai K; Osaki Y; Fukazawa H; Yamada S; Inoshita N; Murakami O; Ohba K; Takahashi K
    Endocr J; 2011; 58(12):1029-36. PubMed ID: 21908929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The limited value of the desmopressin test in the diagnostic approach to Cushing's syndrome.
    Terzolo M; Reimondo G; Alì A; Borretta G; Cesario F; Pia A; Paccotti P; Angeli A
    Clin Endocrinol (Oxf); 2001 May; 54(5):609-16. PubMed ID: 11380491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.